<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="79050">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02066246</url>
  </required_header>
  <id_info>
    <org_study_id>ANA-UKE-PV4374</org_study_id>
    <nct_id>NCT02066246</nct_id>
  </id_info>
  <brief_title>Lung Function After Robot-assisted Radical Prostate Ectomy</brief_title>
  <official_title>Investigation of the Possible Advantages of the AirSeal-system Compared to Conventional CO2 Insufflation Systems in Terms of Lung Function and Hemodynamics in Robot-assisted Laparoscopic Radical Prostate Ectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Prostate Center North West Department of Urology and Pediatric Urology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to investigate if the use of the AirSeal insufflation system impairs
      the lung function of patients less than a conventional system in patients undergoing
      robot-assisted laparoscopic radical prostatectomy (RALP). Therefore we examine the lung
      function before and after surgery.

      As a second purpose of the study, in a subgroup, we investigate the influence of the gas
      insufflators (AirSeal and conventional) on hemodynamics during surgery. Furthermore we study
      the change in the lung perfusion-ventilation-ratio by using the electric impedance
      tomography technique.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>forced vital capacity (FVC)</measure>
    <time_frame>before operation, 1, 24, 120 hours after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>forced expiratory volume in one second (FEV1)</measure>
    <time_frame>before operation, 1, 24, 120 hours after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>ventilation parameters</measure>
    <time_frame>after induction, 30minutes after trendelenburg position, one hour after trendelenburg, two hours after trendelenburg (if operation has not been finished yet), patient in supine position</time_frame>
    <safety_issue>No</safety_issue>
    <description>peak pressure, positive end-expiratory pressure, end-tidal CO2, respiratory rate are recorded during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemodynamic parameters</measure>
    <time_frame>after induction, 30minutes after trendelenburg position, one hour after trendelenburg, two hours after trendelenburg (if operation has not been finished yet), patient in supine position</time_frame>
    <safety_issue>No</safety_issue>
    <description>global end diastolic volume (GEDV), stoke volume variation (SVV); cardiac index (CI), extravascular lung water index (EVLWI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>electric impedance tomography</measure>
    <time_frame>after induction, 30minutes after trendelenburg position, one hour after trendelenburg, two hours after trendelenburg (if operation has not been finished yet), patient in supine position</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Lung Function</condition>
  <arm_group>
    <arm_group_label>Olympus UHI-3</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patients are treated with the Olympus UHI-3-CO2-insufflation and trocar system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AirSeal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients are treated with the AirSeal-CO2-insufflator and trocar-system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AirSeal</intervention_name>
    <description>100 patients are treated with the AirSeal insufflation and trocar system</description>
    <arm_group_label>AirSeal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Olympus UHI-3</intervention_name>
    <description>100 patients are treated with a conventional insufflation and trocar system</description>
    <arm_group_label>Olympus UHI-3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for RALP

          -  Written informed consent

          -  ≥ 18 years of age

        Exclusion Criteria:

          -  Age under 18 years

          -  Patients who refuse participating in the study

          -  Obstructive airway disease (COPD and Asthma)

          -  Postoperative admission to an intensive or intermediate care unit

          -  Patients who do not speak German or English
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel A Reuter, PhD MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf  University of Hamburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander März, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf  University of Hamburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Günter Lippert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prostate Cancer Center North West, at St. Antonius-Hospital, Gronau, Germany .</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Haese, PhD MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jörn Witt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prostate Cancer Center North West, at St. Antonius-Hospital, Gronau, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel A Reuter, PhD MD</last_name>
    <phone>0049 40 7410</phone>
    <phone_ext>52415</phone_ext>
    <email>dreuter@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexander März, MD</last_name>
    <phone>0049 40 7410</phone>
    <phone_ext>52415</phone_ext>
    <email>a.maerz@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Prostate Cancer Center Northwest, at St. Antonius Hospital Gronau</name>
      <address>
        <city>Gronau</city>
        <zip>48599</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Günter Lippert, MD</last_name>
      <phone>02562 915</phone>
      <phone_ext>2400</phone_ext>
      <email>witt@st-antonius-gronau.de</email>
    </contact>
    <contact_backup>
      <last_name>Jörn Witt, MD</last_name>
      <phone>0049 2562 915</phone>
      <phone_ext>2113</phone_ext>
      <email>lippert@st-antonius-gronau.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel A Reuter, PhD MD</last_name>
      <phone>0049 40 7410</phone>
      <phone_ext>52415</phone_ext>
      <email>dreuter@uke.de</email>
    </contact>
    <contact_backup>
      <last_name>Alexander März, MD</last_name>
      <phone>0049 40 7410</phone>
      <phone_ext>52415</phone_ext>
      <email>a.maerz@uke.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 18, 2014</lastchanged_date>
  <firstreceived_date>January 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laparoscopic robot-assisted surger</keyword>
  <keyword>in steep trendelenburg position</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
